Olmesartan medoxomil 40 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB26FHMXW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,445
Award facts
- Contract value 100% obligated
- $12,445.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Olmesartan Medoxomil 40 mg tablets (90-count) with a ceiling value of $12,445.25. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, represents performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award utilized no set-aside designation, indicating competitive procurement against qualified vendors. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical supplies to support defense health operations worldwide. Through its prime IDC vehicle, AmerisourceBergen serves critical customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key vendor in the federal pharmaceutical procurement landscape for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FHMXW?
SPE2DB26FHMXW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FHMXW worth?
The government has obligated $12,445 on SPE2DB26FHMXW.
Is contract SPE2DB26FHMXW an order under another contract?
Yes. SPE2DB26FHMXW is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB26FHMXW competed?
The extent of competition for SPE2DB26FHMXW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award